Intelence (etravirine) / J&J 
Welcome,         Profile    Billing    Logout  

17 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Intelence (etravirine) / J&J
2015-000274-35: clinical trial to assess the safety, tolerability and efficacy of two dolutegravir-based simplification strategies in HIV-infected patients with prolonged virological suppression. ENSAYO CLÍNICO PARA EVALUAR LA SEGURIDAD, TOLERABILIDAD Y EFICACIA DE DOS ESTRATEGIAS DE SIMPLIFICACIÓN BASADAS EN DOLUTEGRAVIR EN PACIENTES INFECTADOS POR VIH CON SUPRESIÓN VIROLÓGICA SOSTENIDA.

Ongoing
4
450
Europe
Lamivudine, Efavirenz, nevirapine, J05AX12, Coated tablet, Capsule, hard, Tablet, Prolonged-release tablet, Tivicay, Stribild, TRUVADA, KIVEXA, ZIAGEN, VIREAD, EMTRIVA, ATRIPLA, EVIPLERA, ISENTRESS, RAYATAZ, PREZISTA, KALETRA, NORVIR, INTELENCE, EDURANT, TRIUMEQ
Fundació Lluita contra la SIDA, Fundació Lluita contra la SIDA
Infection with human immunodeficiency virus (HIV). Infección por el virus de la inmunodeficiencia humana (VIH)., HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
2009-011816-39: A randomised, open label, prospective study to assess two different therapeutic strategies following first treatment failure in HIV-1 infected subjects.‘The First Failure Study’ : ‘FAST’

Ongoing
4
44
Europe
Etravirine, Darunavir, Truvada, Ritonavir, Intelence, Prezista, Truvada, Norvir, Intelence, Prezista, Truvada, Norvir
Imperial College London
HIV
 
 
2010-022201-18: EVALUACIÓN DE LOS NIVELES DE ETRAVIRINA EN LÍQUIDO CEFALORAQUÍDEO (LCR) EN SUJETOS INFECTADOS POR EL VIH

Ongoing
4
10
Europe
INTELENCE 100 mg comprimidos, INTELENCE 100 mg comprimidos
Daniel Podzamczer
antiviral inhibidor no nucleosídico de la transcriptasa inversa
 
 
2011-001463-51: NOT APPLICABLE

Ongoing
4
10
Europe
INTELENCE 100 mg comprimidos, INTELENCE 100 mg comprimidos
Servicio de Enfermedades Infecciosas. Unidad VIH. Hospital Universitari de Bellvitge, HOSPITAL DE BELLVITGE
HIV
 
 
2015-005297-37: Bone Evaluation in women over 40 who Switch from Truvada/NNRTI to Triumeq

Ongoing
4
90
Europe
Tenofovir, Lamivudine, Efavirenz, Nevirapine, Etravirine, Rilpivirine, Film-coated tablet, Tablet, Triumeq, Truvada, Atripla, Eviplera
King's College Hospital NHS Foundation Trust, ViiV Healthcare Ltd
Human Immunodeficiency Virus, People infected with Human Immunodeficiency Virus (HIV), Diseases [C] - Immune System Diseases [C20]
 
 
2017-004750-42: EFFICACY AND SAFETY OF A SIMPLIFICATION TREATMENT BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS USUAL TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS WITH MULTIDRUG RESISTANCE. Eficacia y seguridad de Dolutegravir más Darunavir/cobicistat como tratamiento de simplificación frente al tratamiento habitual en pacientes infectados por el VIH-1 virológicamente suprimidos y con resistencia a múltiples fármacos.

Ongoing
4
100
Europe
lamivudine, Efavirenz, Nevirapine, Film-coated tablet, Coated tablet, Capsule, hard, Tablet, Rezolsta, Tivicay, Ziagen, EMTRIVA, VIREAD, kivexa, Truvada, Intelence, Edurant, Atripla, Eviplera, Reyataz, Prezista, Kaletra, Norvir, Evotaz, Isentress, Stribild, Triumeq, Genvoya, Celsentri, Descovy
FUNDACIÓ LLUITA CONTRA LA SIDA, ViiV Healthcare
HIV-1 VIH-1, HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
NCT04334551: HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance

Recruiting
4
40
Canada, RoW
Doravirine
Clinique du Quartier Latin, Merck Frosst Canada Ltd.
HIV Infections
07/22
10/22
2022-001591-33: Pilot Study of a Switch strategy from Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance Estudio piloto de una estrategia de cambio de etravirina (ETR) a doravirina (DOR) en adultos infectados por VIH-1 virológicamente suprimidos con resistencia a ETR

Not yet recruiting
4
25
Europe
Capsule, PIFELTRO
Fundació Clinic per a la Recerca Biomèdica, MSD
Human Immunodeficiency Virus (HIV) Virus de Inmunodeficiencia Humana (VIH), Human Immunodeficiency Virus (HIV) Virus de Inmunodeficiencia Humana (VIH), Diseases [C] - Virus Diseases [C02]
 
 
NCT05506605: Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance

Active, not recruiting
4
12
Europe
Doravirine 100Mg Tab
Fundacion Clinic per a la Recerca Biomédica
HIV-1-infection
12/24
12/24
2016-002413-22: Open label, Randomized clinical trial to evaluate switching from dual regimens to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in virologically suppressed, HIV-1 infected patients Studio in aperto, randomizzato, per valutare il passaggio da una terapia duplice ad una terapia con E/C/F/TAF in pazienti adulti HIV positivi con carica virale negativa.

Ongoing
3
100
Europe
Tivicay (dolutegravir), Emtriva, Lamivudina, Viread, Ziagen, Edurant, Intelence, Sustiva, Viramune, Film-coated tablet, Capsule, hard, Tablet, Prolonged-release tablet, Genvoya¿ 150 mg/150mg/200mg/10mg, TIVICAY - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) - 30 COMPRESSE, EMTRIVA - 30 CAPSULE RIGIDE IN BLISTER DA 200 MG, LAMIVUDINA MYLAN - 300 MG COMPRESSE RIVESTITE CON FILM 30 COMPRESSE IN BLISTER PVC/PVDC/AL, VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE, ZIAGEN - 300 MG COMPRESSE FILMRIVESTITE 6 BLISTER 10 COMPRESSE USO ORALE, EDURANT - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) 30 COMPRESSE, INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE, SUSTIVA - 600 MG COMPRESSE FILM RIVESTITE 1 FLACONE 30 COMPRESSE USO ORALE, VIRAMUNE - 400 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - BLISTER (PVC/AL) 30 COMPRESSE
OSPEDALE SAN RAFFAELE, Gilead Sciences Inc.
HIV infection Infezione da HIV, HIV infected subjects pazienti affetti da virus HIV, Diseases [C] - Virus Diseases [C02]
 
 
NCT00980538 / 2009-013126-16: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants

Active, not recruiting
3
180
Europe, Canada, US, RoW
Etravirine
Janssen Sciences Ireland UC
HIV Infections, HIV-1
11/20
01/32
2005-003841-14: A pilot evaluation of the pharmacokinetic and safety characteristics of TMC114/ritonavir and TMC125 co-administered to HIV-1-infected subjects with limited treatment options

Ongoing
2
10
Europe
TMC125, TMC114, Norvir, TMC125, TMC114, n/a, Norvir, Norvir
St Stephens AIDS Trust
HIV
 
 
2004-001657-29: A Phase II, randomized, active controlled, open label trial to investigate the efficacy and tolerability of TMC125 in HIV-1 infected subjects, who are PI-naïve and with documented genotypic evidence of NNRTI resistance from previous NNRTI use.A sub-study of TMC125-C227 to evaluate the pharmacokinetic profile at baseline and at week 4 of TMC125 administered in addition to 2 investigators-selected NRTIs (vers. 3.0, 26 sept 2005)

Ongoing
2
12
Europe
TMC125, TMC125 (TF035), TMC125 (spray dry formulation - F060),
Tibotec Pharmaceuticals Limited
HIV-1 infection
 
 
2019-002618-38: Clinical trial - phase II - to test safety and efficay of Etravirine's treatment in Friedreich Studio clinico di fase II per testare sicurezza ed efficacia del trattamento con Etravirina in pazienti con Atassia di Friedreich

Not yet recruiting
2
35
Europe
INTELENCE, [J05AG04], Tablet, INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE
ASSOCIAZIONE "LA NOSTRA FAMIGLIA" - SEZIONE SCIENTIFICA I.R.C.C.S. "E.MEDEA", aCHAF Association, Associazione italiana per la lotta alle sindromi atassiche (A.I.S.A. Onlus), Babel Family, Associazione "OGNI GIORNO" - per Emma onlus, Associazione "Per il Sorriso di Ilaria-Montebruno-Onlus", Università di Roma “Tor Vergata”, Associazione "Un petalo per Margherita Onlus"
Friedreich's ataxia Atassia di Friedreich, Friedreich's ataxia Atassia di Friedreich, Diseases [C] - Nervous System Diseases [C10]
 
 
FAEST1, NCT04273165: Safety and Efficacy of Etravirine in Friedreich Ataxia Patients

Completed
2
30
Europe
Etravirine Tablets
IRCCS Eugenio Medea, University of Rome Tor Vergata
Friedreich Ataxia
01/23
01/23
NCT04194021: Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir

Active, not recruiting
N/A
871
RoW
Elizabeth Glaser Pediatric AIDS Foundation, Janssen, LP
HIV/AIDS
12/22
12/23
SWEED, NCT06155019: Switch From Etravirine to Doravirine as a Part of Antiretroviral Combination

Recruiting
N/A
120
Europe
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
HIV Infections
03/24
06/24

Download Options